HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Novel N Chegou Selected Research

Mycobacterium tuberculosis antigens

1/2022Concurrent evaluation of cytokines improves the accuracy of antibodies against Mycobacterium tuberculosis antigens in the diagnosis of active tuberculosis.
1/2015A Subgroup of Latently Mycobacterium tuberculosis Infected Individuals Is Characterized by Consistently Elevated IgA Responses to Several Mycobacterial Antigens.
12/2014Serologic diagnosis of tuberculosis by combining Ig classes against selected mycobacterial targets.
1/2013Analysis of host responses to Mycobacterium tuberculosis antigens in a multi-site study of subjects with different TB and HIV infection states in sub-Saharan Africa.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Novel N Chegou Research Topics

Disease

30Tuberculosis (Tuberculoses)
01/2022 - 05/2009
11Infections
01/2022 - 05/2009
6HIV Infections (HIV Infection)
10/2021 - 01/2013
5Meningeal Tuberculosis (Tuberculous Meningitis)
09/2022 - 01/2019
5Pulmonary Tuberculosis
01/2018 - 08/2009
4Inflammation (Inflammations)
01/2021 - 08/2009
4Latent Infection
01/2018 - 01/2013
3Spinal Tuberculosis (Pott's Disease)
01/2022 - 01/2021
3Respiratory Tract Diseases (Respiratory Tract Disease)
01/2021 - 01/2017
3Necrosis
01/2021 - 12/2013
2Uveitis
11/2021 - 02/2021
2Body Weight (Weight, Body)
02/2020 - 10/2018
2Hyperglycemia
02/2020 - 12/2013
2Starvation
01/2013 - 01/2012
2Coinfection
01/2013 - 08/2009
1Virus Diseases (Viral Diseases)
01/2022
1Pneumonia (Pneumonitis)
01/2022
1Disease Progression
01/2022
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2022
1Ocular Tuberculosis
11/2021
1Syphilis
02/2021
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2021
1Fibrosis (Cirrhosis)
01/2021
1Back Pain (Backache)
01/2021
1Stroke (Strokes)
01/2021
1Dysbiosis
04/2020
1Reinfection
04/2020
1Metabolic Diseases (Metabolic Disease)
01/2019
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2019
1Obesity
01/2019
1Multidrug-Resistant Tuberculosis (Drug-Resistant Tuberculosis)
01/2018
1Neoplasms (Cancer)
04/2017
1Meningitis
01/2015

Drug/Important Bio-Agent (IBA)

27Biomarkers (Surrogate Marker)IBA
09/2022 - 08/2009
13Proteins (Proteins, Gene)FDA Link
09/2022 - 01/2012
9AntigensIBA
11/2021 - 01/2012
8CytokinesIBA
01/2022 - 08/2009
5Interferon-gamma (Interferon, gamma)IBA
01/2019 - 01/2008
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 05/2009
4Mycobacterium tuberculosis antigensIBA
01/2022 - 01/2013
4Blood Proteins (Serum Proteins)IBA
01/2021 - 01/2016
3Interleukin-6 (Interleukin 6)IBA
01/2017 - 01/2013
3Tuberculin (PPD)IBA
07/2014 - 01/2013
2Pharmaceutical PreparationsIBA
01/2022 - 01/2018
2Ferritins (Ferritin)IBA
01/2021 - 09/2016
2Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link
01/2021 - 01/2013
2Reactive Oxygen Species (Oxygen Radicals)IBA
02/2020 - 04/2017
2Blood Glucose (Blood Sugar)IBA
02/2020 - 10/2018
2Glucose (Dextrose)FDA LinkGeneric
01/2019 - 12/2013
2VaccinesIBA
01/2018 - 01/2012
2Monocyte Chemoattractant ProteinsIBA
04/2017 - 12/2013
2ChemokinesIBA
01/2015 - 08/2009
2GoldIBA
07/2014 - 05/2009
2InterleukinsIBA
01/2014 - 12/2013
2Interleukin-2 (IL2)IBA
01/2014 - 01/2013
2Epidermal Growth Factor (EGF)IBA
08/2009 - 05/2009
1Illicit Drugs (Recreational Drugs)IBA
01/2022
1AntibodiesIBA
01/2022
1Messenger RNA (mRNA)IBA
01/2022
1Apolipoprotein A-I (Apolipoprotein A1)IBA
02/2021
1Lipocalin-2IBA
01/2021
1Growth Differentiation Factor 15IBA
01/2021
1platelet-derived growth factor AIBA
01/2021
1Interleukin-13IBA
01/2021
1fibrin fragment D (D-dimer)IBA
01/2021
1Detergents (Detergent)IBA
12/2020
1RNA (Ribonucleic Acid)IBA
12/2020
1Anti-Bacterial Agents (Antibiotics)IBA
04/2020
1AMP-Activated Protein KinasesIBA
01/2019
1AdiponectinIBA
01/2019
1Oleanolic AcidIBA
01/2019
1Plant ExtractsIBA
10/2018
1Saline SolutionIBA
10/2018
1Immunoglobulin M (IgM)IBA
06/2017
1Immunoglobulin G (IgG)IBA
06/2017
1Immunoglobulin A (IgA)IBA
06/2017
1CholesterolIBA
04/2017
1LDL Lipoproteins (beta Lipoproteins)IBA
04/2017
1Alanine Transaminase (SGPT)IBA
04/2017
1HDL LipoproteinsIBA
04/2017
1Interleukin-1 (Interleukin 1)IBA
04/2017
1Interleukin-16 (Interleukin 16)IBA
04/2017
1Aspartate Aminotransferases (Aspartate Transaminase)IBA
04/2017
1Streptozocin (Streptozotocin)FDA Link
04/2017
1oxidized low density lipoproteinIBA
04/2017
1Alkaline PhosphataseIBA
04/2017
1Neural Cell Adhesion Molecules (Neural Cell Adhesion Molecule)IBA
09/2016
1Prealbumin (Transthyretin)IBA
01/2016
1Fibrinogen (Factor I)FDA Link
01/2016
1Complement Factor H (Factor H)IBA
01/2016
1C-Reactive ProteinIBA
01/2016
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2016
1Interleukin-23 (Interleukin 23)IBA
01/2016
1Peptides (Polypeptides)IBA
07/2014
1AntioxidantsIBA
01/2014
1EnzymesIBA
01/2014
1microsomal triglyceride transfer proteinIBA
01/2014

Therapy/Procedure

3Therapeutics
01/2022 - 03/2013
2Resuscitation
01/2013 - 01/2012
1Duration of Therapy
01/2021